Corcept Therapeutics, Inc. (CORT)
36.26
+0.97
(+2.75%)
USD |
NASDAQ |
Jan 21, 16:00
36.04
-0.22
(-0.61%)
After-Hours: 18:21
Corcept Therapeutics Free Cash Flow: 162.57M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Axsome Therapeutics, Inc. | -101.39M |
| Johnson & Johnson | 20.46B |
| United Therapeutics Corp. | 1.116B |
| Ultragenyx Pharmaceutical, Inc. | -466.39M |
| Amicus Therapeutics, Inc. | 9.691M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 54.48M |
| Cash from Investing (Quarterly) | 14.64M |
| Cash from Financing (Quarterly) | -46.41M |
| Free Cash Flow Per Share (Quarterly) | 0.4561 |
| Free Cash Flow to Equity (Quarterly) | 54.73M |
| Free Cash Flow to Firm (Quarterly) | 54.48M |
| Free Cash Flow Yield | 3.75% |